Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced, Persistent, or Recurrent Endometrial Cancer”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Study completedNCT02228681
What this trial is testing

Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer

Who this might be right for
Advanced, Persistent, or Recurrent Endometrial Cancer
GOG Foundation 74
Testing effectiveness (Phase 2)Study completedNCT00377520
What this trial is testing

A Trial for Patients With Advanced/Recurrent Endometrial Cancer

Who this might be right for
NeoplasmsNeoplasms by SiteUrogenital Neoplasms+8 more
Eli Lilly and Company 27
Testing effectiveness (Phase 2)Study completedNCT00729586
What this trial is testing

Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial CarcinomaRecurrent Uterine Corpus CarcinomaStage IIIA Uterine Corpus Cancer+5 more
National Cancer Institute (NCI) 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT03526432
What this trial is testing

Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer

Who this might be right for
Endometrial Cancer
University of Oklahoma 110
Testing effectiveness (Phase 2)Study completedNCT02725268
What this trial is testing

Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer

Who this might be right for
Endometrial Neoplasms
Millennium Pharmaceuticals, Inc. 241
Testing effectiveness (Phase 2)Study completedNCT00006089
What this trial is testing

Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaERBB2 Gene AmplificationRecurrent Uterine Corpus Carcinoma+2 more
National Cancer Institute (NCI) 34